LACTOLOGY FOUNDATION

Senna glycosides in combinations (ATC A06AB56) are stimulant contact laxatives used for short‑term treatment of constipation; in breastfeeding they are generally compatible in usual doses, with preference for brief, lowest‑effective use and for alternative laxatives if possible.medpedia.framar+4

Pharmacological class and composition

• ATC class: A06AB56 – senna glycosides, combinations, within the group of contact (stimulant) laxatives for the gastrointestinal tract.atcddd.fhi+2
• Active principles: plant‑derived anthranoid glycosides (sennosides A and B and related senna glycosides), usually combined with other laxatives (e.g. bulk‑forming, osmotic, or additional stimulant agents) or excipients that modulate onset and tolerability.drugbank+2
• Mechanistic category: stimulant (contact) laxatives that act predominantly on the colon mucosa to enhance motility and alter fluid and electrolyte handling.bnf.nice+2

Mechanism of action and pharmacokinetics

• After oral intake, senna glycosides pass largely unchanged through the upper gastrointestinal tract and are converted by colonic bacteria to active anthrone metabolites such as rheinanthrone.sciencedirect+1
• These metabolites stimulate colonic peristalsis and reduce water and electrolyte absorption, leading to increased water content, bulk, and softened consistency of stools, which facilitates defecation.webmd+3
• Onset of action after oral administration is typically within 6–12 hours, sometimes up to 24 hours, which is why dosing at bedtime is common; rectal forms (if present in a combination) may act more rapidly.medlineplus+3
• Systemic absorption of intact glycosides is minimal; small amounts of anthraquinone metabolites (e.g. rhein) can be detected systemically and in breast milk, but at levels far below maternal exposures.mims+1

Therapeutic indications

• Short‑term treatment of constipation, including episodic or chronic functional constipation when lifestyle and non‑pharmacological measures are insufficient.wikipedia+3
• Facilitation of bowel emptying prior to diagnostic or surgical procedures, usually as part of a combined bowel preparation regimen.drugbank+2
• In combinations, senna glycosides may be included to counteract drug‑induced constipation (e.g. opioids) or to complement bulk or osmotic laxatives in patients with difficult defecation.breastfeedingnetwork+1

Contraindications and cautions

• Absolute contraindications (systemic, extended to combinations): inflammatory bowel disease such as ulcerative colitis and Crohn’s disease, acute surgical abdomen, appendicitis, intestinal obstruction (ileus), severe abdominal pain of unknown origin, and severe states of dehydration.medpedia.framar+2
• Use is contraindicated or strongly discouraged in children below manufacturer‑specified age cut‑off (often <6–7 years for many formulations) unless specifically directed by a specialist.webmd+3
• Chronic misuse or long‑term daily use may lead to electrolyte disturbances (notably hypokalaemia), secondary constipation, potential colonic atony, and dependence on stimulant laxatives.medlineplus+3
• Particular caution is warranted in older adults, patients with cardiac disease, renal impairment, or on concurrent medications predisposing to electrolyte imbalance.sciencedirect+3

Adverse effects and toxicology

• Common adverse effects: abdominal cramping, colicky pain, flatulence, and diarrhoea; these effects are dose‑dependent and more likely with higher or prolonged dosing.medpedia.framar+2
• Excessive doses or chronic use can precipitate severe diarrhoea with significant fluid and electrolyte losses, most importantly potassium depletion, which can potentiate arrhythmias and neuromuscular symptoms.webmd+2
• Hypokalaemia may enhance cardiotoxicity of digitalis glycosides and increase the risk of adverse effects from other drugs that prolong the QT interval.sciencedirect+2
• Long‑term use of anthranoid laxatives has been associated with reversible pigment deposition in the colonic mucosa (pseudomelanosis coli); its clinical significance for carcinogenesis remains uncertain.wikipedia+1
• Allergic reactions (e.g. skin rash) are rare but possible, particularly in individuals with hypersensitivity to plant‑derived products.medpedia.framar+1

Drug interactions

• Concomitant use with thiazide diuretics, loop diuretics, corticosteroids, or other potassium‑depleting agents may potentiate hypokalaemia.webmd+2
• Hypokalaemia may increase sensitivity to antiarrhythmic agents, especially class I and III drugs, and to digitalis glycosides; careful monitoring or avoidance is recommended.sciencedirect+2
• In combinations that include additional stimulant laxatives, osmotic agents, or stool softeners, cumulative laxative effects may increase the risk of diarrhoea and electrolyte imbalance; dosing should respect the total stimulant load.mims+2

Use during breastfeeding (lactation)

• Lactation risk profile: modern senna preparations at usual therapeutic doses are generally considered compatible with breastfeeding; multiple controlled studies in nursing mothers found no clinically significant effects on infant stool patterns when mothers received standardized senna therapy.ncbi.nlm.nih+3
• Transfer into milk: only negligible amounts of rhein and related metabolites have been detected in breast milk, at levels markedly below maternal systemic concentrations, and typically below thresholds associated with laxative effects in infants.pmc.ncbi.nlm.nih+2
• Infant effects: clinical studies and post‑marketing observations show no consistent increase in diarrhoea or abnormal stool frequency in breastfed infants of mothers treated with senna; sporadic reports of loose stools exist but without confirmed causal relationship when milk levels were undetectable.ncbi.nlm.nih+2
• Clinical recommendations: authoritative breastfeeding resources and national health services allow senna use during lactation when needed, emphasizing short‑term, lowest‑effective dosing and preference for bulk‑forming or osmotic laxatives as first‑line options.nhs+2
• Preparation‑specific guidance: some product information sheets remain precautionary, advising avoidance in breastfeeding unless clearly necessary, reflecting a conservative stance rather than documented toxicity.hpra
• Practical toxicological‑lactological assessment for combinations (A06AB56):
• For healthy term infants, short‑course maternal use of senna‑containing combinations at standard doses is unlikely to cause clinically relevant adverse effects in the breastfed child.sps+4
• Combinations with additional stimulant laxatives may theoretically increase the risk of maternal diarrhoea and electrolyte loss, indirectly affecting lactation and maternal wellbeing rather than directly harming the infant; such regimens should be monitored carefully and limited in duration.breastfeedingnetwork+3
• In preterm infants, neonates with gastrointestinal disease, or infants with significant comorbidities, more conservative choices (non‑stimulant laxatives) are generally preferred.sps+1

Dosing and administration (general adult)

• A06AB56 combinations are usually administered orally once daily, commonly at bedtime, with dosing expressed as total sennoside content; onset of action is expected the following morning.medlineplus+1
• Typical adult doses of senna glycosides (monocomponent) range around 7.5–30 mg of total sennosides at night, with product‑specific maximums; combinations adjust this range according to the presence of other laxative components.mims+1
• Treatment duration should be as short as possible, often limited to a few days and generally not exceeding one week without clinical reassessment, in order to avoid dependence and electrolyte disturbances.medlineplus+3

Access and regulatory status

• Senna glycosides in combinations (A06AB56) are widely available as non‑prescription (over‑the‑counter) preparations in many jurisdictions, reflecting their established role as short‑term laxatives.wikipedia+2
• Despite OTC status, patients should be advised to seek medical evaluation if constipation persists beyond a short course, if they require repeated cycles of stimulant laxatives, or if alarm symptoms (e.g. weight loss, rectal bleeding, anaemia) occur.medpedia.framar+2